![](/static/frontend/img2/jj.png)
Compliance Manager, Monitoring
![](/static/frontend/img2/jj.png)
職位描述
職位描述:
Major Accountabilities :
Cross Functional Collaboration
The candidate for this position must have demonstrated success effectively working and collaborating cross functionally and possess strong communication, interpersonal and organizational skills. The candidate must also have the ability to manage and conduct multiple simultaneous auditing and monitoring initiatives, perform thorough analytical reviews, proactively identify and evaluate trends and prepare meaningful and accurate reports suitable for use in reporting audit results and delivering effective presentations to management and relevant committees. (e.g DCCC)
Monitoring and Control
The candidate for this position will have responsibility for regularly engaging with key business units and process owners, performing independent reviews of business records and transactions, preparing comprehensive analyses and summary reports of audits in effort to proactively identify areas for business enhancements, non-compliance with regulatory guidelines, company policies and/or written standards and mitigate potential compliance issues.
PRIMARY RESPONSIBILITIES
1. In collaboration with Investigations and Monitoring and other key stakeholders, support the implementation of the Integrity & Compliance audit and monitoring program;
2. Represent the I&C function in a manner consistent with established branding standards;
3. Conduct thorough timely audits, review and analyses of various company business records, functions and processes (within Commercial/Field Sales, Marketing and Medical) in accordance with established business rules, audit and monitoring practices and work programs;
4. In conjunction with other I&C teams, participate in various Novartis China national meetings and local programs with the goal of ensuring comprehensive understanding and application of policies and regulations and raising awareness of our compliance program focus on education and prevention;
5. Collaborate with key internal and external business partners in order to support and continuously enhance Audit and Monitoring personnel knowledge and training;
6. Able to effectively utilize various technical applications, navigate through various data systems, gather and analyze data from multiple relevant sources in order to identify trends, patterns of non-compliance and or gaps in established key controls, processes and/or procedures;
7. Effectively share and communicate audit observations, directly initiate and support the development of remediation plan with key stakeholders and executive management;
8. Provide support and assistance to business to ensure the business monitoring plans of specified operations within each focus area are developed and executed as required;
9. Conduct appropriate follow-up and periodic monitoring activities to ensure remediation and corrective action plans are implemented and carried out;
10. Interface and effectively collaborate with various governance committees, third party vendors/contract personnel, the Business Practices Office, legal, HR, and other relevant departments as required;
11. Establish credible and collaborative business cross-functional relationships for the identification of potential areas of non-compliance, as well as ensure adherence to and maintenance of established work programs and processes;
12. Support timely and effective communication and implementation of any new deliverables based on the outcome of audit and monitoring, investigations, risk assessments and Root cause analytics and
13. Perform other duties as assigned.
Job Requirements:
Education: Degree; a minimum of 5 years overall experience and education in either Compliance, Commercial Sales and Marketing or Medical Operations, Audit and Monitoring activities or a related or equivalent discipline.
Travel:Some travel expected as part of assigned duties
Languages: Mandarin mother tongue, English fluent
Experience:
1. Strong Data analytical, interpersonal, communication, and collaborative project management and comprehensive business plan development skills;
2. Working knowledge of in either Compliance, Commercial, Medical and Field support operations, related business engagements, audit and monitoring techniques including risk identification, data testing and validation and root cause analytics;
3. Functional and technical knowledge of various operating systems supporting internal and external business transactions, contractual arrangements, customer interactions, aggregate spend and expense reporting;
4. Support and implementation of new technologies and automation of processes in order to increase department and program efficiencies and productivity; and
5. Maintaining confidentiality of information.
企業(yè)簡介
諾華公司
諾華公司(NYSE: NVS)總部位于瑞士巴塞爾,業(yè)務(wù)遍及全球140多個國家和地區(qū),擁有96,700位全職員工。公司為患者和社會提供醫(yī)藥保健解決方案,以滿足其日益變化的需求。諾華專注于醫(yī)藥保健的增長領(lǐng)域,擁有創(chuàng)新藥品、成本節(jié)約型非專利藥品、預(yù)防性疫苗及診斷試劑,以及消費者保健產(chǎn)品等多元化的業(yè)務(wù)組合,以此最好地滿足患者和社會的需求。諾華是唯一在上述四大領(lǐng)域均處于領(lǐng)先位置的公司。諾華集團2008 年實現(xiàn)凈銷售額增長 9%(以當(dāng)?shù)刎泿庞嫗?nbsp;5%),達415億美元,經(jīng)營收入增長 32%,達90億美元。全球范圍內(nèi),制藥(專利藥)業(yè)務(wù)增長勢頭強勁,疫苗及診斷試劑以及消費者保健品業(yè)務(wù)也有良好表現(xiàn)。
諾華源于拉丁文novae artes,意為“新技術(shù)”。公司的中文名字——諾華,取意承諾中華,即承諾通過不斷創(chuàng)新的產(chǎn)品和服務(wù)致力于提高中國人民的健康水平和生活質(zhì)量。諾華在中國有七家企業(yè)和一家綜合研發(fā)中心,分別是北京諾華制藥有限公司、蘇州諾華制藥科技有限公司、山德士(中國)制藥有限公司及山德士貿(mào)易有限公司, 上海諾華貿(mào)易有限公司, 上海視康貿(mào)易有限公司,上海諾華動物保健有限公司, 諾華(中國)生物醫(yī)學(xué)研究有限公司,總投資超過3.3億美元。目前諾華在中國雇員超過3,500人,2008年總銷售額超過33億元人民幣,比2007年增長29%。
作為公司的價值觀,諾華在歷經(jīng)250年的發(fā)展過程中,在實現(xiàn)業(yè)務(wù)增長的同時,也為患者和員工提供關(guān)愛。目前,盡管全球經(jīng)濟正面臨衰退的壓力, 諾華仍將會繼續(xù)加大在華投資力度, 支持在華業(yè)務(wù)可持續(xù)的增長和擴展。在人才培養(yǎng)方面也進一步加大投入,將成立諾華中國大學(xué)。同時,諾華將在中國創(chuàng)造更多就業(yè)機會,邀請更多人才加入公司,員工總數(shù)將會實現(xiàn)20%增長。這表明諾華對中國市場的信心,更是對“承諾中華”的更好實踐。
北京諾華制藥有限公司
1996年,繼瑞士汽巴-嘉基公司和山德士公司全球完成合并之后,其在華制藥業(yè)務(wù)實施合并,成立了諾華在中國的第一家公司——北京諾華制藥有限公司。
十幾年來,北京諾華制藥取得了驕人的業(yè)績,業(yè)務(wù)遍及全國260多個城市。在過去七年里,北京諾華制藥平均增長速度超過20%,成為諾華集團中增長最高的公司之一。北京諾華制藥2008年銷售增長超過30%,在跨國醫(yī)藥企業(yè)中排名第三。
諾華制藥在中國設(shè)立常用藥品事業(yè)部、抗感染藥品事業(yè)部、移植及中樞神經(jīng)藥品事業(yè)部、眼科藥品事業(yè)部和腫瘤藥品事業(yè)部,實施區(qū)域化管理,建立了極具競爭力的產(chǎn)品組合。公司在心血管、內(nèi)分泌、抗感染、腫瘤、移植免疫、風(fēng)濕疼痛、骨代謝、眼科、中樞神經(jīng)系統(tǒng)等9大領(lǐng)域擁有30多種國際一流的高科技專利產(chǎn)品。
抗高血壓藥品代文?成為中國血管緊張素II受體拮抗劑(ARB)領(lǐng)域市場份額第一的品牌,另一經(jīng)典抗高血壓藥物洛汀新?也繼續(xù)保持同類藥品市場份額第一,洛汀新?和代文?兩種產(chǎn)品2008年銷售額總計突破10億人民幣。公司另一種慢性乙肝治療藥物素比伏?自2007年上市以來,僅用兩年時間即名列市場占有率第3位。諾華制藥還積極推進合規(guī)文化,致力成為履行行業(yè)規(guī)范的領(lǐng)先者,成為中國最具職業(yè)操守的跨國醫(yī)藥企業(yè)之一。
北京諾華制藥也非常重視客戶的需求,致力于提高客戶滿意度。根據(jù)TNS市場研究公司“2008客戶滿意度調(diào)查”,北京諾華制藥連續(xù)四年榮膺客戶滿意調(diào)查榜首。在此基礎(chǔ)上,2009年北京諾華制藥進一步把“患者為本”設(shè)為公司文化建設(shè)的新重點,以為患者提供最優(yōu)質(zhì)的服務(wù)為宗旨,通過持續(xù)創(chuàng)新的各種活動,充分理解患者經(jīng)歷,解除患者病痛,提高患者的生活質(zhì)量。
2009年對于北京諾華制藥而言是“銳勢薄發(fā)”的一年,將有密固達?(骨質(zhì)疏松)、米芙?(移植)、Lescol? XL(降血脂)、Trileptal? OS(抗癲癇)、Exforge?(抗高血壓)和Cibadrex?(抗高血壓)等六個創(chuàng)新產(chǎn)品在中國上市,為廣大患者提供更多有效、安全的藥物選擇。2008年北京諾華制藥通過實施“厚積”項目完善了公司的各項管理制度和流程,提高了運營效率和整體競爭力。在未來五年里,通過開展“薄發(fā)”項目,北京諾華制藥力爭在業(yè)績、人才、企業(yè)美譽度等各方面成為中國醫(yī)藥行業(yè)“標桿企業(yè)”。
北京諾華制藥有限公司制藥廠是由瑞士獨資的制藥工廠,總投資額9000萬美元。工廠坐落在北京市昌平科技園區(qū),占地面積28000平方米,擁有現(xiàn)代化的潔凈廠房和歐洲引進的全套先進設(shè)備,劑型主要為固體和半固體兩種,年產(chǎn)20億片(膠囊)和1200萬支乳膠劑。工廠作為諾華全球標準化GMP工廠之一,統(tǒng)一接受瑞士諾華全球制藥技術(shù)部的技術(shù)和質(zhì)量管理。
職位發(fā)布企業(yè)
![](http://www.dyyiqinggongmao.cn/static/frontend/UploadFiles/company/logo/20170905/zoom_2c8f0462f78048e1e49cfa9d67433c12.png)
北京諾華制藥有限公司
企業(yè)性質(zhì):合資企業(yè)
企業(yè)規(guī)模:10000人以上
成立年份:1996
企業(yè)網(wǎng)址:www.novartis.com.cn
企業(yè)地址:建外大街1號國貿(mào)大廈2座13層
該企業(yè)其他職位更多>>
相關(guān)職位推薦
廣東相關(guān)職位: 市場推廣經(jīng)理 醫(yī)藥信息溝通經(jīng)理(廣州) 銷售總監(jiān) 醫(yī)藥招商經(jīng)理 質(zhì)量管理部部長 固體車間主任 設(shè)備管理員 質(zhì)量負責(zé)人 商采總監(jiān) 工藝員
熱門區(qū)域招聘: 重慶 北京 上海 浙江 江蘇 廣東 山東 湖南 安徽 河北
廣東招聘企業(yè): 中山大學(xué)附屬第一醫(yī)院 廣東奧博藥業(yè)有限公司 廣州肯愛醫(yī)藥生物技術(shù)有限公司 珠海柯諾醫(yī)療科技有限公司 廣東宏健醫(yī)療器械有限公司 貴州益佰制藥股份有限公司 深圳華聲醫(yī)療技術(shù)有限公司 廣州市天河區(qū)棠下街社區(qū)衛(wèi)生服務(wù)中心 廣東聯(lián)合亞太食品藥品物流股份有限公司 廣東聯(lián)合亞太食品藥品物流股份有限公司
職位發(fā)布日期: 2016-11-24